Number of the records: 1
buprenorfín
SYS d002047 LBL 00000nz--a2200000o--4500 005 20250606213758.9 008 920317|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 $d BA006 065 $a D03.132.577.249.150 065 $a D03.605.497.150 065 $a D03.633.400.686.150 065 $a D04.615.723.795.150 066 $a 01 $c 03 150 $a buprenorfín $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 550 $7 sllk_us_auth*d000701 $Y Analgesics, Opioid $w P $a analgetiká opioidné 550 $7 sllk_us_auth*d009292 $Y Narcotic Antagonists $w P $a antagonisty narkotík 550 $7 sllk_us_auth*d009294 $Y Narcotics $w P $a narkotiká 550 $7 sllk_us_auth*d058850 $Y Opiate Substitution Treatment $w p $a liečba opioidmi, substitučná 550 $7 sllk_us_auth*d058850 $Y Opiate Substitution Treatment $w b $a liečba opioidmi, substitučná 665 $a 87(79); was see under MORPHINANS 1979-86 $2 eng 665 $a Dihydromorphinone (1966-1968) $2 eng 665 $a Morphinans (1969-1978) $2 eng 665 $a Morphine (1966-1968) $2 eng 680 9-
$i A derivative of the opioid alkaloid THEBAINE that is a more potent and longer lasting analgesic than MORPHINE. It appears to act as a partial agonist at mu and kappa opioid receptors and as an antagonist at delta receptors. The lack of delta-agonist activity has been suggested to account for the observation that buprenorphine tolerance may not develop with chronic use. $2 eng 680 $a for buprenorphine maintenance treatment, coordinate with OPIATE SUBSTITUTION TREATMENT $2 eng 750 -2
$a Buprenorphine $2 eng 980 $x M
Number of the records: 1